About us

Dr. Michael Riscoe is the director of the Experimental Chemotherapy Laboratory and he is a professor in the Molecular Microbiology and Immunology Department at Oregon Health Sciences University.  Dr. Riscoe's laboratory focuses on the discovery, optimization and development of antiparasitic drugs, especially drugs for treatment and prevention of malaria. Using modern methods of chemical synthesis and drug design his laboratory has developed novel antimalarial chemotypes that are orally bioavailable and curative in mouse models of malaria.


Department of Veterans Affairs
National Institutes of Health
Medicines for Malaria Venture